EUVIMEDEUVIMED entdecken
Leserbrief

Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19 ‐directed CAR T‐cell therapy in diffuse large B cell lymphoma

Nicolas Gazeau iD, Suman Mitra, Morgane Nudel, Remi Tilmont, Paul Chauvet, Micha Srour, Anne-Sophie Moreau, Pauline Varlet, Enagnon Kazali Alidjinou, Salomon Manier iD, Franck Morschhauser, Myriam Labalette und 2 weitere

British Journal of Haematology · 2023

DOI: 10.1111/bjh.18775 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Nicolas Gazeau und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, CHU Lille, 59000, Lille, France. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveLymphoma, Large B-Cell, DiffuseHumansNivolumabT-LymphocytesAntigens, CD19

Substanzen

NivolumabAntigens, CD19

Autor:innen und Institutionen

  • Hematology Department, CHU Lille, 59000, Lille, France.
  • CANTHER, INSERM UMR-S1277 & CNRS UMR9020, Lille University, 59000, Lille, France.
  • Critical Care Center, CHU de Lille, 59000, Lille, France.
  • Immunology Institute, CHU Lille, 59000, Lille, France.
  • Lille University, Inserm U1286-Infinite, 59000, Lille, France.
  • University Lille, CHU Lille, Laboratoire de Virologie ULR3610, F-59000, Lille, France.

ORCID-Profile: Nicolas Gazeau, Salomon Manier, David Beauvais

Zitieren

APA

Gazeau, N., Mitra, S., Nudel, M., Tilmont, R., Chauvet, P., Srour, M., Moreau, A. S., Varlet, P., Alidjinou, E. K., Manier, S., Morschhauser, F., Labalette, M., Yakoub-Agha, I., & Beauvais, D. (2023). Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19 ‐directed CAR T‐cell therapy in diffuse large B cell lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.18775

Vancouver

Gazeau N, Mitra S, Nudel M, Tilmont R, Chauvet P, Srour M, et al. Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19 ‐directed CAR T‐cell therapy in diffuse large B cell lymphoma. British Journal of Haematology. 2023. doi:10.1111/bjh.18775

BibTeX
@article{Gazeau2023,
  author = {Gazeau, Nicolas and Mitra, Suman and Nudel, Morgane and Tilmont, Remi and Chauvet, Paul and Srour, Micha and Moreau, Anne-Sophie and Varlet, Pauline and Alidjinou, Enagnon Kazali and Manier, Salomon and Morschhauser, Franck and Labalette, Myriam and Yakoub-Agha, Ibrahim and Beauvais, David},
  title = {Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19 ‐directed CAR T‐cell therapy in diffuse large B cell lymphoma},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.18775}
}
Kostenlos starten →